COFEPRIS attends 219 technical sessions for the pharmaceutical sector
COFEPRIS reported that it had attended 219 technical sessions from January to August this year, focusing on...
Bayer global CEO visits Mexico
Manuel Bravo, president and CEO of Bayer in Mexico opened his offices' doors to global number one...
The medicine market in Mexico grows 29%
It was announced that in times of pandemic, the national pharmaceutical market registered growth in demand with...
Clinical laboratories in Mexico strengthen strategies for drug development and access
The Ministry of Health of Mexico highlighted that the National Network of Public Health Laboratories had become...
Pharmaceutical companies in Mexico foresee growth of 36% amid the crisis
The Mexican pharmaceutical industry estimated this Wednesday a growth of 36% in the production of medicines for...
The Ministry of Health and Navy create in Mexico Intelligence Center against Sanitary Risks
The Ministry of Health, through the Federal Commission for the Protection against Sanitary Risks (COFEPRIS), and the...
INSABI and UNOPS start delivery of medicines and medical supplies in the second half of 2022
INSABI and UNOPS have maintained a continuous supply; More than one million medicines and medical supplies are...
Oswaldo Bernal appointed as new director of Bristol Myers Squibb Mexico
The biopharmaceutical company Bristol Myers Squibb (BMS) today announced the appointment of Oswaldo Bernal as the new...
Investing in Cannabis is safe for economic growth in Mexico: Industry Experts
The cannabis industry in Mexico has increased its production, consumption, research and development through not only medicinal...
New investment of the pharmaceutical sector in the State of Mexico
The company Neolpharma will invest in the State of Mexico and will expand its plants in Ecatepec...